药物对比
Linagliptin vs Insulin Detemir
Linagliptin 与 Insulin Detemir 治疗糖尿病的比较。口服DPP-4抑制剂与长效胰岛素：作用机制、用途、疗效、副作用及偏好方面的差异。
此页面暂无可用的对比维度。
临床背景
This comparison arises when deciding between adding an oral DPP-4 inhibitor or initiating basal insulin in type 2 diabetes patients whose current therapy is insufficient.
结论
Selection depends on diabetes severity, oral versus injectable preference, hypoglycemia risk and comorbidities rather than one drug being superior.
全部药物对比